IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells

Y Chen, J Liu, P Lv, J Gao, M Wang… - Cell adhesion & …, 2018 - Taylor & Francis
Various survival factors such as the pleiotropic cytokine interleukin-6 (IL-6), a major mediator
of inflammation and activator of signal transducer and activator of transcription 3 (STAT3) …

[HTML][HTML] IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells

Y Chen, J Liu, P Lv, J Gao, M Wang… - Cell Adhesion & …, 2018 - ncbi.nlm.nih.gov
Various survival factors such as the pleiotropic cytokine interleukin-6 (IL-6), a major mediator
of inflammation and activator of signal transducer and activator of transcription 3 (STAT3) …

IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells

Y Chen, J Liu, P Lv, J Gao… - Cell adhesion & …, 2018 - pubmed.ncbi.nlm.nih.gov
Various survival factors such as the pleiotropic cytokine interleukin-6 (IL-6), a major mediator
of inflammation and activator of signal transducer and activator of transcription 3 (STAT3) …

IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells.

Y Chen, J Liu, P Lv, J Gao, M Wang… - Cell Adhesion & …, 2017 - europepmc.org
Various survival factors such as the pleiotropic cytokine interleukin-6 (IL-6), a major mediator
of inflammation and activator of signal transducer and activator of transcription 3 (STAT3) …

IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells.

Y Chen, J Liu, P Lv, J Gao, M Wang… - Cell Adhesion & …, 2017 - europepmc.org
Various survival factors such as the pleiotropic cytokine interleukin-6 (IL-6), a major mediator
of inflammation and activator of signal transducer and activator of transcription 3 (STAT3) …